|
Lesions | Model | Status of SOX9 | Effects | References |
|
Acinar-to-ductal metaplasia | Mice | Overexpressed | HNF6 induces Sox9 expression, which is characteristic of ADM in humans | [34, 35] |
|
Acinar-to-ductal metaplasia | Mice | Overexpressed | Aberrant expression of p27 induces the nuclear expression of Sox9 | [36] |
|
Mucinous cystic neoplasias, intraductal papillary mucinous neoplasias, pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinoma | Mice | Overexpressed | SOX9 and Kras co-expression is associated with PDAC initiation | [37] |
|
Pancreatic ductal adenocarcinoma | 88 tumors samples of PDAC | Overexpressed | Sox9 and p-Akt double-positive expression is related with an unfavorable prognosis, high TNM and distant metastasis | [38] |
|
Pancreatic ductal adenocarcinoma | Patient-derived tumor organoids with PDAC | Overexpressed in cytoplasm | High expression of Sox9 in cytoplasm is related with a poor DFS, OS, higher tumor grade and worse disease-specific survival compared to patients with nuclear Sox9 expression | [39] |
|
Pancreatic cancer | PANC1 and HPAC cell lines of pancreatic cancer | Overexpressed | Sox9 is highly expressed in pancreatic CSCs. Moreover, NF-κB subunit p65 positively regulates SOX9 | [40] |
|
Pancreatic ductal adenocarcinoma | HD3 colon cancer cells | Overexpressed | ST6Gal-I induces expression of Sox9, promoting stem-like cell properties | [41] |
|
Pancreatic cancer | PANC-1, Capan-1, BxPC-3, MiaPaCa-2 cell lines of pancreatic cancer | Expression depending on chemoresistance | High level of Sox9 is related to stronger chemoresistance to Gemcitabine | [42] |
|
Pancreatic ductal adenocarcinoma | HPDE cell line of PDAC | Overexpressed | GLI1 induces the transcription of Sox9 promoting stem cell properties | [43] |
|
Pancreatic cancer | PANC1 cell line of pancreatic cancer | Downregulated | Induction of EMT with TGF-β results in low levels of SOX9, FOXA2, and GATA4 | [44] |
|
Pancreatic cancer | Mice | Overexpressed | p53-/- mice enhanced sphere formation, increased expression of the stemness regulator Bmi1 and Klf4, and pancreatic multipotent progenitor markers as Ptf1a, Pdx1, Cpa1, c-myc, Hnf1b and Sox9 | [45] |
|
Pancreatic cancer | FG and L3.6pl cell lines of pancreatic cancer under hypoxia | Overexpressed | Under hypoxia conditions, FG cell line expresses high levels of Sox9 and L3.6pl. Besides, WNT, CXCR4, retinoic acid, and FAK signaling pathways are regulated by Sox9 in L3.6pI | [46] |
|
Pancreatic ductal adenocarcinoma and anaplastic pancreatic cancer | 6 APC patients and 53 PDAC patients | Overexpressed | PDAC and APC have high expression of Sox9, being the expression of proteins related with CSCs and EMT process higher in APC samples than PDAC | [30] |
|
Intraductal papillary mucinous neoplasm | 19 IPMN cases | Overexpressed | SOX9-positive cells were confined to the lower portions of the papillary structures of IPMN | [47] |
|
Solid pseudopapillary tumor | 8 samples of SPT | Overexpressed | PDX1 and Sox9 are both expressed in the cytoplasm of SPT cell | [48] |
|